#1 Clinical Trials Search in Europe

Artemisia Vulgaris Pollen Extract

This article discusses clinical trials investigating the use of Artemisia Vulgaris Pollen Extract, commonly known as mugwort pollen extract, in treating allergies. These studies aim to evaluate the effectiveness and safety of this extract in various forms of immunotherapy for patients with allergic conditions, particularly allergic rhinitis and rhinoconjunctivitis.

Table of Contents

What is ARTEMISIA VULGARIS POLLEN EXTRACT?

ARTEMISIA VULGARIS POLLEN EXTRACT is a substance derived from the pollen of the mugwort plant (Artemisia vulgaris). This extract is used in medical settings, particularly for diagnostic purposes and potentially for treatment of certain allergic conditions[1]. Mugwort is a common weed found in many parts of the world, and its pollen is a known allergen for some people.

Medical Uses

The primary medical use of ARTEMISIA VULGARIS POLLEN EXTRACT is in allergy testing, specifically for diagnosing mugwort pollen allergies. It is a component of skin prick tests, which are used to identify specific allergens that may be causing allergic reactions in patients[1].

While the extract is primarily used for diagnostic purposes, research is ongoing to explore its potential therapeutic applications, particularly in the field of allergen-specific immunotherapy. This type of therapy aims to reduce sensitivity to specific allergens over time[2].

How is it Administered?

ARTEMISIA VULGARIS POLLEN EXTRACT is typically administered in the following ways:

  • Skin Prick Test: A small amount of the extract is placed on the skin, usually on the forearm or back, and the skin is then pricked. This allows a tiny amount of the allergen to enter the skin. If a person is allergic, a small, itchy bump will appear at the site within about 15 minutes[1].
  • Solution for Topical Use: The extract is available as a solution for skin-prick tests, typically in a concentration of 30 HEP/ml (Histamine Equivalent Prick units per milliliter)[1].

Current Clinical Trials

While the provided clinical trial information doesn’t specifically focus on ARTEMISIA VULGARIS POLLEN EXTRACT, it’s worth noting that this extract is often used in allergy research alongside other common allergens. The trials mentioned are investigating treatments for various pollen allergies, which could potentially inform future research on mugwort pollen allergy treatments[3][4][4].

Potential Side Effects and Precautions

As with any medical procedure or substance, there are potential risks and side effects to be aware of:

  • Allergic Reactions: In rare cases, severe allergic reactions (anaphylaxis) can occur during skin prick tests. This is why these tests are always performed under medical supervision[1].
  • Skin Irritation: Some people may experience temporary itching, redness, or swelling at the test site[1].
  • False Positives/Negatives: As with any diagnostic test, there is a possibility of false positive or false negative results[1].

It’s important to inform your healthcare provider of any medications you’re taking, as some can interfere with the test results. Additionally, people with certain skin conditions or severe allergies may not be suitable candidates for skin prick tests[1].

Conclusion

ARTEMISIA VULGARIS POLLEN EXTRACT plays a crucial role in diagnosing mugwort pollen allergies. While its primary use is in skin prick tests, ongoing research may uncover potential therapeutic applications in the future. As with any medical procedure, it’s important to discuss the risks and benefits with your healthcare provider to determine if allergy testing with this extract is appropriate for your individual situation.

Aspect Details
Study Type Phase II-III clinical trials
Main Conditions Studied Moderate to severe allergic rhinitis/rhinoconjunctivitis due to various pollen types
Primary Objective To assess efficacy and safety of immunotherapy treatments for pollen allergies
Treatment Forms Sublingual and subcutaneous immunotherapy
Key Outcome Measures Combined Symptom and Medication Score (CSMS), quality of life improvements
Role of Artemisia Vulgaris Extract Used in skin prick tests for allergy diagnosis
Patient Age Range 18-65 years
Key Inclusion Criteria Positive skin prick test, specific IgE levels, history of allergic symptoms
Safety Assessments Monitoring of adverse events, local and systemic reactions

FAQ

  • What is Artemisia Vulgaris Pollen Extract? Artemisia Vulgaris Pollen Extract, also known as mugwort pollen extract, is a substance derived from the pollen of the mugwort plant. It is used in allergy testing and treatment, particularly for people allergic to mugwort pollen.
  • How is Artemisia Vulgaris Pollen Extract used in these clinical trials? In these trials, Artemisia Vulgaris Pollen Extract is primarily used as a diagnostic tool in skin prick tests. It helps identify allergies to mugwort pollen in patients with conditions like allergic rhinitis or rhinoconjunctivitis.
  • What types of allergies are being studied in these trials? The trials are focusing on various pollen allergies, including birch pollen, grass pollen, and olive pollen. While Artemisia Vulgaris is not the main treatment, it's used to help diagnose and understand patients' allergic profiles.
  • What are the main goals of these clinical trials? The main goals are to assess the efficacy and safety of different immunotherapy treatments for allergic rhinitis and rhinoconjunctivitis. They aim to find the most effective doses and methods of administration for various pollen extracts.
  • Who can participate in these clinical trials? Generally, adults aged 18-65 with moderate to severe allergic rhinitis or rhinoconjunctivitis due to specific pollen allergies can participate. Participants must meet certain criteria, including positive skin prick tests and specific IgE levels to the allergens being studied.

Ongoing Clinical Trials on Artemisia Vulgaris Pollen Extract

  • Study on the Effectiveness and Safety of Allergenic Extract of Olea Europaea Pollen for Patients with Moderate-to-Severe Olive Pollen Allergy

    Not recruiting

    4 1 1
    Investigated drugs:
    Spain

  • Study on the Effectiveness and Safety of Phleum Pratense Pollen Extract for Patients with Moderate-to-Severe Grass Pollen Allergy

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

    Not recruiting

    3 1 1
    Investigated drugs:
    Austria Bulgaria Germany Latvia Lithuania Poland

  • Study on the Effectiveness and Safety of Sublingual Immunotherapy with Betula Pendula Pollen Extract for Patients with Birch Pollen Allergy

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

Glossary

  • Allergic rhinitis: An allergic reaction affecting the nose, causing symptoms like sneezing, runny nose, and nasal congestion in response to allergens such as pollen.
  • Rhinoconjunctivitis: A combination of rhinitis (nasal symptoms) and conjunctivitis (eye symptoms) caused by allergies, affecting both the nose and eyes.
  • Immunotherapy: A treatment approach that aims to modify the immune system's response to allergens, potentially reducing allergic symptoms over time.
  • Skin prick test: A diagnostic method used to identify specific allergies by applying small amounts of allergens to the skin and observing the reaction.
  • IgE (Immunoglobulin E): An antibody produced by the immune system in response to allergens, playing a key role in allergic reactions.
  • ARIA guideline: Allergic Rhinitis and its Impact on Asthma guideline, a set of recommendations for diagnosing and managing allergic rhinitis.
  • FEV1: Forced Expiratory Volume in 1 second, a measure of lung function used to assess respiratory health.
  • CSMS: Combined Symptom and Medication Score, a method used to evaluate the effectiveness of allergy treatments by considering both symptom severity and medication use.
  • Nasal Provocation Test: A diagnostic procedure where allergens are applied to the nasal mucosa to assess allergic reactions.
  • RQLQ: Rhinoconjunctivitis Quality of Life Questionnaire, a tool used to measure how allergies affect a person's quality of life.

References

  1. http://clinicaltrials.eu/trial/study-on-the-effectiveness-of-purethal-mites-for-adults-with-moderate-to-severe-allergic-rhinitis-or-rhinoconjunctivitis-due-to-house-dust-mite-allergy/
  2. http://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-sublingual-immunotherapy-with-betula-pendula-pollen-extract-for-patients-with-birch-pollen-allergy/
  3. http://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-phleum-pratense-pollen-extract-for-patients-with-moderate-to-severe-grass-pollen-allergy/
  4. http://clinicaltrials.eu/trial/study-on-the-effectiveness-and-safety-of-allergenic-extract-of-olea-europaea-pollen-for-patients-with-moderate-to-severe-olive-pollen-allergy/